Aug 2013

Benznidazole and Posaconazole in experimental Chagas disease: Positive interaction in concomitant and sequential treatments

PLoS Negl Trop Dis.

by de Figueiredo Diniz L, Urbina JA, Mayer de Andrade I, Mazzeti AL, Martins TAF, Santana Caldas I,Talvani A, Ribeiro I, Terezinha MB. PLoS Negl Trop Dis., August 2013.

Click here to access the article / PDF

Chagas disease

Latest scientific articles

Loading...

Scientific articles

30 Sep 2025

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

BMJ Open

Scientific articles

29 Sep 2025

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala

Journal of the Brazilian Society of Tropical Medicine

Scientific articles

22 Sep 2025

Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans

Antimicrobial Agents and Chemotherapy

Scientific articles

18 Sep 2025

Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of eumycetoma

RSC Medicinal Chemistry

VIEW ALL

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

Linkedin-in Instagram Twitter Facebook-f Youtube

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Diseases

Neglected tropical diseases

R&D portfolio

Policy advocacy

Get in touch

Our offices

Contact us

Integrity Line

Support us

Donate

Subscribe to eNews

Work with us

Join research networks

Jobs

RFPs

Terms of Use

  Acceptable Use Policy

  Privacy Policy

  Cookie Policy

  Our policies

Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license